CDKN2A variants in a population-based sample of queensland families with melanoma

被引:159
|
作者
Aitken, J [1 ]
Welch, J [1 ]
Duffy, D [1 ]
Milligan, A [1 ]
Green, A [1 ]
Martin, N [1 ]
Hayward, N [1 ]
机构
[1] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
来源
关键词
D O I
10.1093/jnci/91.5.446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Mutations in the CDKN2A gene confer susceptibility to cutaneous malignant melanoma (CMM); however, the population incidence of such mutations is unknown, Polymorphisms in CDKN2A have also been described, but it is not known whether they influence melanoma risk, We investigated the association of CDKN2A mutations and polymorphisms nifh melanoma risk in a population-based sample of families ascertained through probands with melanoma, Methods: The 482 Queensland, Australia, families in our sample were characterized previously as having high, intermediate, or low family risk of CMM. Unrelated individuals (n = 200 families/individuals) drawn from the Australian Twin Registry served as control subjects. For individuals in the high-risk group, the entire CDKN2A gene coding region was screened for mutations by use of the polymerase chain reaction, agarose gel electrophoresis, allele-specific oligonucleotide (ASO) hybridization, and single-strand conformation polymorphism analysis, The intermediate- and low-risk families and control subjects were analyzed by ASO hybridization for a total of six recurring mutations as well as for polymorphisms at nucleotides (Nts) 442, 500, and 540, Results: CDKN2A mutations were found only in the high-risk families (nine [10.3%] of 87), The prevalence of the Nt500G (guanosine) polymorphism increased linearly with increasing familial risk (two-sided P = .02) and was highest in the nine (primarily Celtic) families with CDKN2A mutations. After adjustment for ethnic origin, the relationship between risk group and the frequency of the Nt500G allele was weakened (P = .25); however, there was no relationship between ethnic origin and Nt500-polymorphism frequency among the control subjects. Conclusions: CDKN2A mutations are rare in this population (approximately 0.2% of all melanoma cases in Queensland) and appear to be associated with melanoma in only the most affected families, The Nt500G allele appears to be associated with familial risk, but this association probably reflects Celtic ancestry.
引用
收藏
页码:446 / 452
页数:7
相关论文
共 50 条
  • [1] Population-based prevalence of CDKN2A mutations in Utah melanoma families
    Eliason, Mark J.
    Larson, April A.
    Florell, Scott R.
    Zone, John J.
    Cannon-Albright, Lisa A.
    Samlowski, Wolfram E.
    Leachman, Sancy A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (03) : 660 - 666
  • [2] CDKN2A common variants and their association with melanoma risk:: A population-based study
    Debniak, T
    Scott, RJ
    Huzarski, T
    Byrski, T
    Rozmiarek, A
    Debniak, B
    Zaluga, E
    Maleszka, R
    Kladny, J
    Górski, B
    Cybulski, C
    Gronwald, J
    Kurzawski, G
    Lubinski, J
    CANCER RESEARCH, 2005, 65 (03) : 835 - 839
  • [3] Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample
    Begg, CB
    Orlow, I
    Hummer, AJ
    Armstrong, BK
    Kricker, A
    Marrett, LD
    Millikan, RC
    Gruber, SB
    Anton-Culver, H
    Zanetti, R
    Gallagher, RP
    Dwyer, T
    Rebbeck, TR
    Mitra, N
    Busam, K
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (20): : 1507 - 1515
  • [4] Ocular melanoma is not associated with CDKN2A or MC1R variants -: a population-based study
    Vajdic, C
    Kricker, A
    Duffy, DL
    Aitken, JF
    Stark, M
    ter Huurne, JAC
    Martin, NG
    Armstrong, BK
    Hayward, NK
    MELANOMA RESEARCH, 2003, 13 (04) : 409 - 413
  • [5] Penetrance of CDKN2A mutations estimated using population-based Australian families
    Jenkins, Mark
    Cust, Anne
    Schmidt, Daniel
    Makalic, Enes
    Holland, Elizabeth
    Scmid, Helen
    Kefford, Richard
    Giles, Graham
    Bruce, Armstrong
    Aitkin, Joanne
    Mann, Graham
    Hopper, John
    GENETIC EPIDEMIOLOGY, 2009, 33 (08) : 811 - 812
  • [6] Germline variants in CDKN2A wild-type melanoma prone families
    Iversen, Gjertrud T.
    Loeng, Marie
    Holth, Amalie Lund
    Lonning, Per E.
    Geisler, Jurgen
    Knappskog, Stian
    MOLECULAR ONCOLOGY, 2025,
  • [7] Germline variants in CDKN2A wild-type melanoma prone families
    Knappskog, Stian
    Iversen, Gjertrud T.
    Loeng, Marie
    Holth, Amalie L.
    Lonning, Per E.
    Geisler, Jurgen
    CANCER RESEARCH, 2024, 84 (06)
  • [8] CDKN2A mutations in melanoma families from Uruguay
    Borges, A. L.
    Cuellar, F.
    Puig-Butille, J. A.
    Scarone, M.
    Delgado, L.
    Badenas, C.
    Mila, M.
    Malvehy, J.
    Barquet, V.
    Nunez, J.
    Laporte, M.
    Fernandez, G.
    Levrero, P.
    Martinez-Asuaga, M.
    Puig, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (03) : 536 - 541
  • [9] Mutation screening of the CDKN2A promoter in melanoma families
    Harland, M
    Holland, EA
    Ghiorzo, P
    Mantelli, M
    Bianchi-Scarrà, G
    Goldstein, AM
    Tucker, MA
    Ponder, BAJ
    Mann, GJ
    Bishop, DT
    Bishop, JN
    GENES CHROMOSOMES & CANCER, 2000, 28 (01): : 45 - 57
  • [10] CDKN2A mutations in Canadian malignant melanoma families.
    Summers, AM
    Hogg, D
    Shennan, M
    Lassam, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A324 - A324